Search research articles
Contact Us
Filters
Showing results (271-280 of 599) with videos related to
Page
of 60
Sort By:
European Journal of Medicinal Chemistry
|
December 3, 2019
Conjugable A<sub>3</sub> adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes
Stephanie Federico, Enrico Margiotta, Stefano Moro, et al.
Bioorganic & Medicinal Chemistry
|
January 9, 2003
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors
Vita Ozola, Mark Thorand, Martina Diekmann, et al.
Pain
|
September 23, 2014
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways
Kali Janes, Emanuela Esposito, Timothy Doyle, et al.
Cells
|
May 16, 2020
Allosteric Antagonism of the A<sub>2A</sub> Adenosine Receptor by a Series of Bitopic Ligands
Zhan-Guo Gao, Kiran S Toti, Ryan Campbell, et al.
Biochemical Pharmacology
|
March 8, 2003
Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors
Seong G Kim, Kelly A Soltysiak, Zhan-Guo Gao, et al.
Experimental Eye Research
|
May 11, 2007
Barrier qualities of the mouse eye to topically applied drugs
Zhao Wang, Chi Wai Do, Marcel Y Avila, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists
Susanna Tchilibon, Bhalchandra V Joshi, Soo-Kyung Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 4, 2004
Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog
Mariya Chhatriwala, R Gnana Ravi, Roshni I Patel, et al.
Biochemical Pharmacology
|
July 2, 2011
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers
Zhan-Guo Gao, Dennis Verzijl, Annelien Zweemer, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Adenosine Kinase Expression Determines DNA Methylation in Cancer Cell Lines
Amir E Wahba, Denise Fedele, Hoda Gebril, et al.
Page
of 60
Search research articles
Search
Showing results (271-280 of 599) with videos related to
Sort By:
Page
of 60
European Journal of Medicinal Chemistry
|
December 3, 2019
Conjugable A<sub>3</sub> adenosine receptor antagonists for the development of functionalized ligands and their use in fluorescent probes
Stephanie Federico, Enrico Margiotta, Stefano Moro, et al.
Bioorganic & Medicinal Chemistry
|
January 9, 2003
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors
Vita Ozola, Mark Thorand, Martina Diekmann, et al.
Pain
|
September 23, 2014
A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways
Kali Janes, Emanuela Esposito, Timothy Doyle, et al.
Cells
|
May 16, 2020
Allosteric Antagonism of the A<sub>2A</sub> Adenosine Receptor by a Series of Bitopic Ligands
Zhan-Guo Gao, Kiran S Toti, Ryan Campbell, et al.
Biochemical Pharmacology
|
March 8, 2003
Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors
Seong G Kim, Kelly A Soltysiak, Zhan-Guo Gao, et al.
Experimental Eye Research
|
May 11, 2007
Barrier qualities of the mouse eye to topically applied drugs
Zhao Wang, Chi Wai Do, Marcel Y Avila, et al.
Journal of Medicinal Chemistry
|
March 18, 2005
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists
Susanna Tchilibon, Bhalchandra V Joshi, Soo-Kyung Kim, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
September 4, 2004
Induction of novel agonist selectivity for the ADP-activated P2Y1 receptor versus the ADP-activated P2Y12 and P2Y13 receptors by conformational constraint of an ADP analog
Mariya Chhatriwala, R Gnana Ravi, Roshni I Patel, et al.
Biochemical Pharmacology
|
July 2, 2011
Functionally biased modulation of A(3) adenosine receptor agonist efficacy and potency by imidazoquinolinamine allosteric enhancers
Zhan-Guo Gao, Dennis Verzijl, Annelien Zweemer, et al.
ACS Pharmacology & Translational Science
|
April 16, 2021
Adenosine Kinase Expression Determines DNA Methylation in Cancer Cell Lines
Amir E Wahba, Denise Fedele, Hoda Gebril, et al.
Page
of 60